Logo image of CYBE.CA

CYBERCATCH HOLDINGS INC (CYBE.CA) Stock Fundamental Analysis

Canada - TSX-V:CYBE - CA23250C2013 - Common Stock

6.89 CAD
+0.08 (+1.17%)
Last: 10/14/2025, 7:00:00 PM
Fundamental Rating

1

CYBE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 62 industry peers in the Software industry. CYBE has a bad profitability rating. Also its financial health evaluation is rather negative. CYBE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CYBE has reported negative net income.
In the past year CYBE has reported a negative cash flow from operations.
CYBE.CA Yearly Net Income VS EBIT VS OCF VS FCFCYBE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

With a Return On Assets value of -146.64%, CYBE is not doing good in the industry: 83.87% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -146.64%
ROE N/A
ROIC N/A
ROA(3y)-785.51%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CYBE.CA Yearly ROA, ROE, ROICCYBE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

With a Gross Margin value of 40.67%, CYBE perfoms like the industry average, outperforming 46.77% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for CYBE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CYBE.CA Yearly Profit, Operating, Gross MarginsCYBE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

2

2. Health

2.1 Basic Checks

CYBE does not have a ROIC to compare to the WACC, probably because it is not profitable.
CYBE has about the same amout of shares outstanding than it did 1 year ago.
CYBE has a worse debt/assets ratio than last year.
CYBE.CA Yearly Shares OutstandingCYBE.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M 4M 5M
CYBE.CA Yearly Total Debt VS Total AssetsCYBE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

CYBE has an Altman-Z score of 25.25. This indicates that CYBE is financially healthy and has little risk of bankruptcy at the moment.
CYBE's Altman-Z score of 25.25 is amongst the best of the industry. CYBE outperforms 95.16% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 25.25
ROIC/WACCN/A
WACC11.24%
CYBE.CA Yearly LT Debt VS Equity VS FCFCYBE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M -4M -6M -8M -10M

2.3 Liquidity

A Current Ratio of 0.48 indicates that CYBE may have some problems paying its short term obligations.
CYBE has a Current ratio of 0.48. This is in the lower half of the industry: CYBE underperforms 77.42% of its industry peers.
A Quick Ratio of 0.48 indicates that CYBE may have some problems paying its short term obligations.
CYBE's Quick ratio of 0.48 is on the low side compared to the rest of the industry. CYBE is outperformed by 77.42% of its industry peers.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.48
CYBE.CA Yearly Current Assets VS Current LiabilitesCYBE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

CYBE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.47%, which is quite impressive.
Looking at the last year, CYBE shows a very strong growth in Revenue. The Revenue has grown by 144.72%.
EPS 1Y (TTM)79.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.43%
Revenue 1Y (TTM)144.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-8.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CYBE.CA Yearly Revenue VS EstimatesCYBE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 200K 400K 600K 800K 1M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CYBE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYBE.CA Price Earnings VS Forward Price EarningsCYBE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYBE.CA Per share dataCYBE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CYBE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYBERCATCH HOLDINGS INC

TSX-V:CYBE (10/14/2025, 7:00:00 PM)

6.89

+0.08 (+1.17%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-30 2025-06-30
Earnings (Next)02-11 2026-02-11
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners23.04%
Ins Owner ChangeN/A
Market Cap174.18M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 353.88
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.02
BVpS-0.04
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -146.64%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.67%
FCFM N/A
ROA(3y)-785.51%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.48
Quick Ratio 0.48
Altman-Z 25.25
F-Score5
WACC11.24%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)144.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-8.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y69.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y86.11%
OCF growth 3YN/A
OCF growth 5YN/A